007. The largest research and development expense for the three
months ended June 30, 2008 was payroll costs to build a highly qualified
research and development team.
VentriPoint reported a foreign exchange loss of $99,568 as the result
of a change in the currency exchange rate used to translate Canadian
monetary items into the US dollar on the date of translation of June 30,
About VentriPoint Diagnostics
VentriPoint creates diagnostic tools to monitor patients with heart
disease -- the number one cause of death in developed countries. By using
images produced from existing medical imaging systems, the VentriPoint
Diagnostic System generates accurate heart measurements in a rapid and
inexpensive manner not currently available. This breakthrough diagnostic
tool is based upon patented technology received by VentriPoint through its
exclusive technology license with the University of Washington. The
VentriPoint Diagnostic System, together with its associated online service,
is being developed for a variety of heart related disease states, including
congenital heart disease.
For further information, please contact:
Edward Garth, Chief Financial Officer
VentriPoint Diagnostics Ltd.
Telephone: (206) 283-0221, ext. 402
Facsimile: (206) 283-2309
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
VentriPoint Media Contact:
Russo Partners LLC
Page: 1 2 Related biology technology :1
|SOURCE VentriPoint Diagnostics|
Copyright©2008 PR Newswire.
All rights reserved
. VentriPoint, University of Washington Sign Research and Technology Development Agreement2
. Strategic Diagnostics to Present at Two Upcoming Investor Conferences3
. Strategic Diagnostics Updates Roth Conference Presentation Time4
. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University5
. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference6
. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development7
. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference8
. BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards9
. Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections10
. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions11
. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)